Dosage regimen of an s1p receptor modulator
作者： Robert Schmouder , Olivier David , Craig Boulton , Irene Hunt , Ana de Vera
DOI:
关键词:
摘要: S1P receptor modulators are administered following a dosage regimen providing positive benefit-risk profile.
lens.org 参考文章(39)
Joseph S. Bresee, Scott F. Dowell, Severe Varicella Associated With Steroid Use Pediatrics. ,vol. 92, pp. 223- 228 ,(1993)
Robert Schmouder, Michael Looby, Olivier David, Thomas Dumortier, Dosage regimen for a s1p receptor agonist ,(2009)
Per Lindquist, Treatment of disorders of nervous systemsystem with fty720 ,(2004)
Thomas Lathrop Stedman, Stedman's Medical Dictionary ,(1942)
G Niklas Norén, I Ralph Edwards, Modern methods of pharmacovigilance: detecting adverse effects of drugs. Clinical Medicine. ,vol. 9, pp. 486- 489 ,(2009) , 10.7861/CLINMEDICINE.9-5-486
Stuart L. Nightingale, From the Food and Drug Administration JAMA: The Journal of the American Medical Association. ,vol. 264, pp. 2372- 1394 ,(1990) , 10.1001/JAMA.1990.03450180026007
R.L. Zuvich, J.L. McCauley, M.A. Pericak-Vance, J.L. Haines, Genetics and pathogenesis of multiple sclerosis. Seminars in Immunology. ,vol. 21, pp. 328- 333 ,(2009) , 10.1016/J.SMIM.2009.08.003
Ludwig Kappos, Jack Antel, Giancarlo Comi, Xavier Montalban, Paul O'Connor, Chris H. Polman, Tomas Haas, Alexander A. Korn, Goeril Karlsson, Ernst W. Radue, Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis The New England Journal of Medicine. ,vol. 355, pp. 1124- 1140 ,(2006) , 10.1056/NEJMOA052643
Richard Nicholas, Paolo Giannetti, Ali Alsanousi, Tim Friede, Paolo A Muraro, Development of oral immunomodulatory agents in the management of multiple sclerosis Drug Design Development and Therapy. ,vol. 5, pp. 255- 274 ,(2011) , 10.2147/DDDT.S10498
Anne A. Gershon, Michael D. Gershon, Judith Breuer, Myron J. Levin, Anne Louise Oaklander, Paul D. Griffiths, Advances in the understanding of the pathogenesis and epidemiology of herpes zoster Journal of Clinical Virology. ,vol. 48, ,(2010) , 10.1016/S1386-6532(10)70002-0